Angiodynamics (ANGO) Other Gross PP&E Adjustments (2016 - 2025)
Angiodynamics (ANGO) has disclosed Other Gross PP&E Adjustments for 15 consecutive years, with -$11.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments fell 10.1% year-over-year to -$11.0 million, compared with a TTM value of -$11.0 million through Nov 2025, down 10.1%, and an annual FY2025 reading of -$3.5 million, down 160.96% over the prior year.
- Other Gross PP&E Adjustments was -$11.0 million for Q4 2025 at Angiodynamics, up from -$11.2 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $93.0 million in Q2 2023 and bottomed at -$23.4 million in Q3 2021.
- Average Other Gross PP&E Adjustments over 5 years is $2.4 million, with a median of -$11.2 million recorded in 2023.
- The sharpest move saw Other Gross PP&E Adjustments surged 41.61% in 2024, then tumbled 160.96% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at -$18.0 million in 2021, then grew by 16.59% to -$15.0 million in 2022, then rose by 24.6% to -$11.3 million in 2023, then grew by 11.61% to -$10.0 million in 2024, then dropped by 10.1% to -$11.0 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for ANGO at -$11.0 million in Q4 2025, -$11.2 million in Q3 2025, and -$3.5 million in Q2 2025.